Mack Gene (CIK 0001737979)

Latest company ownership

Shares held
14,400
Last filed at
Aug 12, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 9, 2024 Aug 12, 2024 Gain Therapeutics, Inc. CEO Buy 91.3 +14,400 100.00% $14.5K